XML 47 R38.htm IDEA: XBRL DOCUMENT v3.23.3

Certain Transactions - Other Transactions - Additional Information (Detail) - USD ($) $ in Millions		1 Months Ended			3 Months Ended			9 Months Ended
	Jun. 12, 2023	Oct. 31, 2021	Aug. 31, 2021	Dec. 31, 2016	Sep. 30, 2022	Jun. 30, 2022	Dec. 31, 2021	Sep. 30, 2023	Oct. 03, 2023	Sep. 29, 2023
Johnson And Johnson [Member] | Settlement And License Agreement Alvotech And Teva [Member]
Noncash or Part Noncash Acquisitions [Line Items]
Maximum entry date for granting license entry	Feb. 21, 2025
Takeda [Member]
Noncash or Part Noncash Acquisitions [Line Items]
Upfront payment				$ 30
Milestone payment				20		$ 25
Collaborative agreement milestone payments				$ 519
Alvotech [Member]
Noncash or Part Noncash Acquisitions [Line Items]
Collaborative agreement milestone payments								$ 400
Alvotech [Member] | Subordinated Convertible Bonds [Member]
Noncash or Part Noncash Acquisitions [Line Items]
Cost of the investment										$ 40
MedinCell [Member]
Noncash or Part Noncash Acquisitions [Line Items]
Milestone payment					$ 3
Collaborative agreement milestone payments			$ 105
MODAG [Member]
Noncash or Part Noncash Acquisitions [Line Items]
License agreement potential aggregate milestone payments amount		$ 30
MODAG [Member] | Research and Development Expense [Member]
Noncash or Part Noncash Acquisitions [Line Items]
Milestone payment							$ 10
Subsequent Event [Member] | Sanofi [Member] | Collaborative Arrangement [Member]
Noncash or Part Noncash Acquisitions [Line Items]
Milestone payment receivable									$ 500
Development and launch milestone payment receivable									$ 1,000

X

- Definition

Collaborative Agreement Milestone Payments

+ References

No definition available.

+ Details

Name:	teva_CollaborativeAgreementMilestonePayments
Namespace Prefix:	teva_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

X

- Definition

Development and launch milestone payment receivable.

+ References

No definition available.

+ Details

Name:	teva_DevelopmentAndLaunchMilestonePaymentReceivable
Namespace Prefix:	teva_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

X

- Definition

License agreement potential aggregate milestone payments amount.

+ References

No definition available.

+ Details

Name:	teva_LicenseAgreementPotentialAggregateMilestonePaymentsAmount
Namespace Prefix:	teva_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

X

- Definition

Maximum entry date for granting license entry.

+ References

No definition available.

+ Details

Name:	teva_MaximumEntryDateForGrantingLicenseEntry
Namespace Prefix:	teva_
Data Type:	xbrli:dateItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Milestone payment.

+ References

No definition available.

+ Details

Name:	teva_MilestonePayment
Namespace Prefix:	teva_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

X

- Definition

Milestone payment receivable.

+ References

No definition available.

+ Details

Name:	teva_MilestonePaymentReceivable
Namespace Prefix:	teva_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

X

- Definition

Upfront payments

+ References

No definition available.

+ Details

Name:	teva_UpfrontPayments
Namespace Prefix:	teva_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

X

- Definition

Cost of the investment.

+ References

Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Topic 946
-SubTopic 210
-Name Accounting Standards Codification
-Section 55
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480493/946-210-55-1

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 210
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Subparagraph (a)(1)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480524/946-210-50-6

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 210
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Subparagraph (a)(2)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480524/946-210-50-6

Reference 4: http://www.xbrl.org/2003/role/exampleRef
-Topic 946
-SubTopic 830
-Name Accounting Standards Codification
-Section 55
-Paragraph 12
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480167/946-830-55-12

Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 946
-SubTopic 210
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Subparagraph (a)(3)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480524/946-210-50-6

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.6-03(d))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.12-12(Column C)(Footnote 8)(a)(3))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.12-12B(Column C)(Footnote 11)(a)(3))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 6
-Subparagraph (SX 210.12-14(Column F)(Footnote 5)(a))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 19
-Subparagraph (3)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480032/946-320-S99-19

+ Details

Name:	us-gaap_InvestmentOwnedAtCost
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

X

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

No definition available.

+ Details

Name:	us-gaap_NoncashOrPartNoncashAcquisitionsLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Details

Name:	srt_CounterpartyNameAxis=teva_JohnsonAndJohnsonMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	teva_AgreementAxis=teva_SettlementAndLicenseAgreementAlvotechAndTevaMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_BusinessAcquisitionAxis=teva_TakedaMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_BusinessAcquisitionAxis=teva_AlvotechMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_DebtInstrumentAxis=teva_SubordinatedConvertibleBondsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_BusinessAcquisitionAxis=teva_MedincellMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_BusinessAcquisitionAxis=teva_ModagMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	srt_CounterpartyNameAxis=teva_SanofiMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: